Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9441 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9441 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9214 |
High Similarity |
NPD1510 |
Phase 2 |
0.9155 |
High Similarity |
NPD1549 |
Phase 2 |
0.9149 |
High Similarity |
NPD2796 |
Approved |
0.9122 |
High Similarity |
NPD4380 |
Phase 2 |
0.9085 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9085 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.906 |
High Similarity |
NPD7411 |
Suspended |
0.9007 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.894 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8929 |
High Similarity |
NPD1240 |
Approved |
0.8889 |
High Similarity |
NPD7075 |
Discontinued |
0.8816 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7819 |
Suspended |
0.8803 |
High Similarity |
NPD1607 |
Approved |
0.8766 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD6801 |
Discontinued |
0.8701 |
High Similarity |
NPD7768 |
Phase 2 |
0.8671 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD3750 |
Approved |
0.8627 |
High Similarity |
NPD1934 |
Approved |
0.8591 |
High Similarity |
NPD6799 |
Approved |
0.8591 |
High Similarity |
NPD1511 |
Approved |
0.8571 |
High Similarity |
NPD2801 |
Approved |
0.8571 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8481 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8477 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8421 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8408 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8377 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8367 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8322 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8302 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8301 |
Intermediate Similarity |
NPD920 |
Approved |
0.8299 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8289 |
Intermediate Similarity |
NPD5401 |
Approved |
0.828 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8193 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD7054 |
Approved |
0.817 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8163 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8146 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8121 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8113 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8052 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8052 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8052 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7976 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7973 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7908 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD919 |
Approved |
0.7887 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7881 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7848 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7815 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7805 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD943 |
Approved |
0.777 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7762 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7712 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7684 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7625 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7605 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7554 |
Intermediate Similarity |
NPD7584 |
Approved |
0.755 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7003 |
Approved |
0.744 |
Intermediate Similarity |
NPD5710 |
Approved |
0.744 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7418 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7401 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7386 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7343 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7303 |
Intermediate Similarity |
NPD411 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7289 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7207 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7169
|
Intermediate Similarity |
NPD6280 |
Approved |